跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FILSPARI 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FILSPARI 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
FILSPARI 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Vifor France
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 20, 2024
Approval ID
16ff7a21462474f1
Company
Vifor France
Type
Standard
Approval Details
Approval Id
16ff7a21462474f1
Drug Cima Aemps Name
FILSPARI 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1231788002
Holder Company Name
Vifor France
Marketing Company Name
Vifor Pharma Espana S.L.
Holder Company Detail Path
/organization/vifor-france-sasu
Authorization Date
2024-09-20
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
400 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Vifor France
Company Detail Path
/organization/vifor-france-sasu
Company Information
Pharmaceutical Company Name
Vifor France SASU
Country Name
France
Website
http://www.viforpharma.fr
Active Ingredients
ESPARSENTAN
400 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 20, 2024
Approval ID
16ff7a21462474f1
Type
Standard
Back to CIMA-AEMPS Approvals
